17:53:46 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-12 X-dag ordinarie utdelning PHI 0.00 SEK
2024-09-16 Kvartalsrapport 2025-Q1
2024-08-19 Extra Bolagsstämma 2025
2024-06-26 Bokslutskommuniké 2024
2024-03-27 Kvartalsrapport 2024-Q3
2023-12-21 Kvartalsrapport 2024-Q2
2023-11-15 Extra Bolagsstämma 2024
2023-10-27 Årsstämma 2024
2023-10-13 X-dag ordinarie utdelning PHI 0.00 SEK
2023-09-20 Kvartalsrapport 2024-Q1
2023-06-23 Bokslutskommuniké 2023
2023-05-09 Extra Bolagsstämma 2023
2023-03-28 Kvartalsrapport 2023-Q3
2022-12-21 Kvartalsrapport 2023-Q2
2022-10-31 Årsstämma 2023
2022-10-14 X-dag ordinarie utdelning PHI 0.00 SEK
2022-09-29 Kvartalsrapport 2023-Q1
2022-06-29 Bokslutskommuniké 2022
2022-03-21 Kvartalsrapport 2022-Q3
2022-03-15 Extra Bolagsstämma 2022
2021-12-29 Kvartalsrapport 2022-Q2
2021-10-20 Extra Bolagsstämma 2021
2021-10-11 X-dag ordinarie utdelning PHI 0.00 SEK
2021-09-29 Kvartalsrapport 2022-Q1
2021-06-24 Bokslutskommuniké 2021
2021-03-16 Kvartalsrapport 2021-Q3
2020-12-14 Kvartalsrapport 2021-Q2
2020-10-20 Årsstämma 2021
2020-10-15 X-dag ordinarie utdelning PHI 0.00 SEK
2020-09-28 Kvartalsrapport 2021-Q1
2020-06-25 Bokslutskommuniké 2020
2020-03-12 Kvartalsrapport 2020-Q3
2019-12-17 Kvartalsrapport 2020-Q2
2019-10-16 X-dag ordinarie utdelning PHI 0.00 SEK
2019-10-15 Årsstämma 2020
2018-09-27 X-dag ordinarie utdelning PHI 0.00 SEK
2018-09-26 Årsstämma 2019
2018-06-18 Extra Bolagsstämma 2019
2018-06-12 Bokslutskommuniké 2018
2018-03-12 Kvartalsrapport 2018-Q3
2017-09-26 X-dag ordinarie utdelning PHI 0.00 SEK
2017-09-25 Årsstämma 2018
2017-09-11 Kvartalsrapport 2018-Q1
2017-06-19 Bokslutskommuniké 2017
2017-03-13 Kvartalsrapport 2017-Q3
2017-01-01 Extra Bolagsstämma 2018
2016-11-30 Kvartalsrapport 2017-Q2
2016-09-06 X-dag ordinarie utdelning PHI 0.00 SEK
2016-09-05 Årsstämma 2017
2016-09-05 Kvartalsrapport 2017-Q1
2016-06-13 Bokslutskommuniké 2016
2016-02-22 Kvartalsrapport 2016-Q3
2016-02-16 Extra Bolagsstämma 2017
2015-11-30 Kvartalsrapport 2016-Q2
2015-09-08 X-dag ordinarie utdelning PHI 0.00 SEK
2015-09-07 Kvartalsrapport 2016-Q1
2015-09-07 Årsstämma 2016
2015-06-16 Bokslutskommuniké 2015
2015-03-16 Kvartalsrapport 2015-Q3
2014-12-01 Kvartalsrapport 2015-Q2
2014-10-07 X-dag ordinarie utdelning PHI 0.00 SEK
2014-10-06 Årsstämma 2015
2014-10-06 Kvartalsrapport 2015-Q1
2014-06-30 Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Phase Holographic Imaging PHI är verksamt inom medicinteknik. Bolaget utvecklar instrument och mjukvara för time-lapse cytometri. Produkterna används för kvantitativ långtidsanalys av levande cellers dynamik, särskilt av betydelse inom cancerforskning, samt vid behandling av inflammatoriska - samt autoimmuna sjukdomar. Produkterna säljs på global nivå via bolagets distributörer och störst närvaro återfinns inom Norden. Huvudkontoret ligger i Lund.
2024-06-13 11:32:46

Phase Holographic Imaging (PHI) is pleased to announce a strategic expansion into the Spanish and Portuguese markets, facilitated by a new subcontract between its global distribution partner, Altium, and Paralab. As PHI's global distributor partner, Altium has leveraged its autonomy to enhance PHI's market reach, making HoloMonitor technology close at hand to customers on the Iberian Peninsula.

In November 2023, PHI established a distribution agreement with Altium, empowering them to market and sell PHI's products within designated territories. This agreement authorizes Altium to utilize its broad distributor network and global sales contacts, actively opening new markets for PHI's innovative technologies.

Following the agreement, Altium has started to skillfully handle the entire sales process and local customer relations for the HoloMonitor product line. To streamline and improve these efforts, Altium recently appointed Daniel Soor as the dedicated PHI distributor partner manager, significantly enhancing the global reach and sales performance of PHI's HoloMonitor technology.

Building on these efforts, Altium has now advanced PHI's market expansion strategies by entering into a distribution agreement with Paralab. In Spain, the pharmaceutical and biotechnology sectors are not only dynamic but also among the most competitive globally, making this move a pivotal development in PHI's ongoing efforts to expand its international footprint.

PHI's CEO, Patrik Eschricht, expresses:

"We are excited to see HoloMonitor taking a strong market foothold through our collaboration with Altium. Expanding in Spain and Portugal is not merely strategic; it underscores our commitment to advancing global healthcare and research."

About Paralab
Paralab (https://paralab.es/) is a company dedicated to the distribution of scientific instrumentation for laboratories and processes. It represents leading manufacturers of instrumentation for chemical, pharmaceutical and mechanical analysis, focusing its activities on instrumentation sales, technical assistance and user training. Its main objective is to satisfy its customers' needs in terms of quality and service.